Little is known about the expression of the receptor for complement anaphylatoxin C3a (C3aR) in the central nervous system (CNS). In this study, we provide the first evidence that neurons are the predominant cell type expressing C3aR in the normal CNS. By using in situ hybridization (ISH) and immuno
Expression of the murine complement regulatory protein Crry by glial cells and neurons
β Scribed by Nathalie Davoust; Serge Nataf; V. Michael Holers; Scott R. Barnum
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 371 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0894-1491
No coin nor oath required. For personal study only.
β¦ Synopsis
The expression of the murine complement regulatory protein, Crry, in the CNS remains largely unexplored. In this study, we examined murine astrocytes and microglia purified from neonatal brain and sections of adult murine brain for the expression of Crry. Using RT-PCR, immunohistochemistry, in situ hybridization, flow cytometry, and Western blot analysis, we demonstrated that astrocytes and microglia express Crry protein and RNA. Crry expression is greater on microglia than astrocytes and, as determined by Western blot analysis, each cell type expresses a Crry protein of different molecular weight. Interestingly, neuronal expression of Crry was seen only at the RNA level. These data demonstrate Crry expression by astrocytes, microglia, and neurons in the murine CNS and suggest that Crry may play an important role in protecting the CNS against complement-mediated damage.
π SIMILAR VOLUMES
tein they
## Chemokine gene expression and chemokine activity appear to be major components of the immunopathological processes of inflammation and autoimmunity. To initiate an investigation of the role of chemokines in the pathogenesis of autoimmune inflammatory demyelination, we examined the expression of
## Abstract ## Objective Following the demonstration that the stress protein, BiP, prevented induction of collagenβinduced arthritis (CIA) in HLAβDRB\*0101^+/+^ (HLAβDR1^+/+^) mice, we investigated the immunotherapeutic ability of BiP to suppress disease during the active phase of CIA in HLAβDR1^+